1377P Preliminary efficacy and safety results of KN026 (a HER2-targeted bispecific antibody) in combination with KN046 (an anti-PD-L1/CTLA-4 bispecific antibody) in patients (pts) with HER2-positive gastrointestinal tumors
Authors:
- J. GongJGJ. Gong
- L. ShenLSL. Shen
- S. LuoSLS. Luo
- Z. DongZDZ. Dong
- D. LiuDLD. Liu
- S. AnSAS. An
- J. XuJXJ. Xu
- J. YangJYJ. Yang
- Y. QiYQY. Qi
- J. MenJMJ. Men
- L. KongLKL. Kong
- Y. YangYYY. Yang
- 1 September 2021
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 32, S1042